- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for Hospira Inc (HSP)
| Open: | 35.7300 | Day's Range: | 35.5400 - 36.2200 | Volume: | 1,630,343 |
|---|---|---|---|---|---|
| Previous Close: | 35.7400 | 52wk Range: | 28.6200 - 37.7800 | 1-Yr Rtn: | +12.96% |
Key Statistics for HSP
| Current P/E Ratio (ttm) | 20.3630 |
|---|---|
| Estimated P/E(12/2013) | 17.6908 |
| Relative P/E vs. SPX | 1.2564 |
| Earnings Per Share (USD) (ttm) | 1.7561 |
| Est. EPS (USD) (12/2013) | 2.0310 |
| Est. PEG Ratio | 1.8880 |
| Market Cap (M USD) | 5,918.01 |
| Shares Outstanding (M) | 165.49 |
| 30 Day Average Volume | 1,332,734 |
| Price/Book (mrq) | 1.9960 |
| Price/Sale (ttm) | 1.4825 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/01/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HSP
Company Profile & Key Executives for HSP
Hospira, Inc. is a global pharmaceutical and medication delivery company that develops, manufactures and markets products. The Company's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira products are used by hospitals, clinics, home healthcare providers and long-term care facilities.
| F Michael Ball "Mike"Chief Executive Officer | Richard J DaviesSenior VP/Chief Commercial Ofcr |
| Thomas Edward WernerSenior VP:Finance/CFO | Sumant RamachandraSenior VP/Chief Scientic Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HSP News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page